Isotopologue multipoint calibration for proteomics biomarker quantification in clinical practice

Mostra el registre complet Registre parcial de l'ítem

  • dc.contributor.author Chiva, Cristina
  • dc.contributor.author Pastor, Olga
  • dc.contributor.author Trilla Fuertes, Lucía
  • dc.contributor.author Gámez Pozo, Angelo
  • dc.contributor.author Fresno Vara, Juan Ángel
  • dc.contributor.author Sabidó Aguadé, Eduard, 1981-
  • dc.date.accessioned 2019-07-31T06:10:24Z
  • dc.date.issued 2019
  • dc.description.abstract Targeted proteomics has become the method of choice for biomarker validation in human biopsies due to its high sensitivity, reproducibility, accuracy, and precision. However, for targeted proteomics to be transferred to clinical routine there is the need to reduce its complexity, make its procedures simpler, increase its throughput, and improve its analytical performance. Here we present the Isotopologue Multipoint Calibration (ImCal) quantification strategy, which uses a mix of isotopologue peptides to generate internal multipoint calibration curves for each individual sample and to accurately quantify biomarker peptides in clinical applications without the need of expert supervision. ImCal relies on the use of five different isotopically-labelled peptides of different nominal mass mixed at different concentrations to be used as an internal calibration curve for each endogenous peptide. The use of internal multipoint calibration curves is well-suited for the generation of ready-to-use biomarker kits for clinical applications as it is compatible with both high- and low-resolution mass spectrometers and different levels of endogenous peptide, it eliminates the need for blank matrixes required in external curves, it allows the evaluation of matrix effects and the valid quantification range in each individual sample, and it does not require expert adjustment. We used the ImCal method to quantify HER2 in 35 breast cancer formalin-fixed paraffin-embedded patient samples, revealing a high degree of heterogeneity among patients, which contrasts with the homogeneous immunohistochemistry patient classification. Our work illustrates how an improvement of mass spectrometry methods for biomarker quantification can provide fine-grain patient stratification, and thus better disease diagnostic and prognosis.
  • dc.description.sponsorship The CRG/UPF Proteomics Unit is part of the Spanish Infrastructure for Omics Technologies (ICTS OmicsTech) and it is a member of the ProteoRed PRB3 consortium which is supported by Grant PT17/0019/0021 of the PE I+D+i 2013-2016 from the Instituto de Salud Carlos III (ISCIII) and ERDF. We acknowledge support from the Spanish Ministry of Science, Innovation and Universities, “Centro de Excelencia Severo Ochoa 2013–2017”, Grant SEV-2012-0208, and “Secretaria d’Universitats i Recerca del Departament d’Economia i Coneixement de la Generalitat de Catalunya” Grant (2017SGR595). This project has also received funding from the European Union’s Horizon 2020 research and innovation program under Grant Agreement No. 823839 (EPIC-XS). L.T.-F. is supported by Spanish Economy and Competitiveness Ministry (Grant DI-15-07614). The Molecular Oncology and Pathology Lab is supported by Instituto de Salud Carlos III, Spanish Economy and Competitiveness Ministry, Spain, and cofunded by the FEDER program, “Una forma de hacer Europa” (Grant PI15/01310).
  • dc.format.mimetype application/pdf
  • dc.identifier.citation Chiva C, Pastor O, Trilla-Fuertes L, Gámez-Pozo A, Fresno Vara JÁ, Sabidó E. Isotopologue multipoint calibration for proteomics biomarker quantification in clinical practice. Anal Chem. 2019;91(8):4934-8. DOI: 10.1021/acs.analchem.8b05802
  • dc.identifier.doi http://dx.doi.org/10.1021/acs.analchem.8b05802
  • dc.identifier.issn 0003-2700
  • dc.identifier.uri http://hdl.handle.net/10230/42208
  • dc.language.iso eng
  • dc.publisher American Chemical Society (ACS)
  • dc.relation.ispartof Analytical Chemistry. 2019;91(8):4934-8
  • dc.relation.projectID info:eu-repo/grantAgreement/EC/H2020/823839
  • dc.rights This document is the Accepted Manuscript version of a Published Work that appeared in final form in Analytical chemistry, copyright © American Chemical Society after peer review and technical editing by the publisher. To access the final edited and published work see http://dx.doi.org/[núm.DOI].
  • dc.rights.accessRights info:eu-repo/semantics/openAccess
  • dc.title Isotopologue multipoint calibration for proteomics biomarker quantification in clinical practice
  • dc.type info:eu-repo/semantics/article
  • dc.type.version info:eu-repo/semantics/acceptedVersion